Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply
Are you familiar with the AETC Program HIV Care Tools App?
graphic image

Join the MidAtlantic AETC for an interactive discussion on implementing long-acting injectable protocols for HIV Care and Prevention. In recent years, the use of long-acting injectables in HIV care and prevention has been an impactful tool for treating and preventing HIV infections. 

Objectives

  • Describe the role of long-acting injectable therapies in the treatment and prevention of HIV.
  • Compare currently available long-acting agents in terms of mechanism, dosing schedule, and indications.
  • Explain the clinical trial data supporting the use of lenacapavir for HIV PrEP.
  • Identify appropriate candidates for long-acting injectable PrEP and ART, with consideration for adherence, stigma, and access barriers.

Speaker

Caitlin Prather, PharmD, BCACP, AAHIVP, TTS
Clinical Pharmacy Specialist, Juniper and Pride Clinics 
Residency Program Director, PGY2 Ambulatory Care

More events in this series